PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer

Cell

Volumn 160, Issue 4, 2015, Pages 700-714

  Bonavita, Eduardo ^a   Gentile, Stefania ^a   Rubino, Marcello ^a   Maina, Virginia ^a   Papait, Roberto ^a,b   Kunderfranco, Paolo ^a   Greco, Carolina ^a   Feruglio, Francesca ^a   Molgora, Martina ^a   Laface, Ilaria ^a   Tartari, Silvia ^a   Doni, Andrea ^a   Pasqualini, Fabio ^a   Barbati, Elisa ^a   Basso, Gianluca ^a   Galdiero, Maria Rosaria ^a   Nebuloni, Manuela ^c   Roncalli, Massimo ^a   Colombo, Piergiuseppe ^a   Laghi, Luigi ^a   Lambris, John D ^d   Jaillon, Sébastien ^a   Garlanda, Cecilia ^a   Mantovani, Alberto ^a,e   more..

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Milan Unit   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e HUMANITAS UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT FACTOR H; PENTRAXIN 3; C REACTIVE PROTEIN; COMPLEMENT; SERUM AMYLOID P;

ANGIOGENESIS; ARTICLE; CELL INFILTRATION; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOKINE PRODUCTION; DNA DAMAGE; DNA METHYLATION; GENE EXPRESSION; IMMUNOREACTIVITY; INNATE IMMUNITY; MACROPHAGE; MICROORGANISM; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TUMOR VOLUME; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MUTATION; NEOPLASM; TUMOR SUPPRESSOR GENE;

MUS;

ANIMALS; C-REACTIVE PROTEIN; COMPLEMENT SYSTEM PROTEINS; DNA METHYLATION; GENES, P53; HUMANS; INFLAMMATION; MICE; MUTATION; NEOPLASMS; SERUM AMYLOID P-COMPONENT;

EID: 84922689090     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.01.004     Document Type: Article

References (56)

1. B. Akhtar-Zaidi, R. Cowper-Sal-lari, O. Corradin, A. Saiakhova, C.F. Bartels, D. Balasubramanian, L. Myeroff, J. Lutterbaugh, A. Jarrar, and M.F. Kalady Epigenomic enhancer profiling defines a signature of colon cancer Science 336 2012 736 739
2. P. Andreu, M. Johansson, N.I. Affara, F. Pucci, T. Tan, S. Junankar, L. Korets, J. Lam, D. Tawfik, and D.G. DeNardo FcRgamma activation regulates inflammation-associated squamous carcinogenesis Cancer Cell 17 2010 121 134
3. N.K. Banda, G. Mehta, V.P. Ferreira, C. Cortes, M.C. Pickering, M.K. Pangburn, W.P. Arend, and V.M. Holers Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis J. Immunol. 190 2013 3560 3569
4. B. Bottazzi, V. Vouret-Craviari, A. Bastone, L. De Gioia, C. Matteucci, G. Peri, F. Spreafico, M. Pausa, C. D'Ettorre, and E. Gianazza Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component J. Biol. Chem. 272 1997 32817 32823
5. B. Bottazzi, A. Doni, C. Garlanda, and A. Mantovani An integrated view of humoral innate immunity: pentraxins as a paradigm Annu. Rev. Immunol. 28 2010 157 183
6. A. Braunschweig, and M. Józsi Human pentraxin 3 binds to the complement regulator c4b-binding protein PLoS ONE 6 2011 e23991
7. M. Chiarini, C. Sabelli, P. Melotti, C. Garlanda, G. Savoldi, C. Mazza, R. Padoan, A. Plebani, A. Mantovani, and L.D. Notarangelo PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients Genes Immun. 11 2010 665 670
8. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 2009 1073 1081
9. L.M. Coussens, L. Zitvogel, and A.K. Palucka Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339 2013 286 291
10. C. Cunha, F. Aversa, J.F. Lacerda, A. Busca, O. Kurzai, M. Grube, J. Löffler, J.A. Maertens, A.S. Bell, and A. Inforzato Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation N. Engl. J. Med. 370 2014 421 432
11. K.E. de Visser, L.V. Korets, and L.M. Coussens Early neoplastic progression is complement independent Neoplasia 6 2004 768 776
12. L. Deban, H. Jarva, M.J. Lehtinen, B. Bottazzi, A. Bastone, A. Doni, T.S. Jokiranta, A. Mantovani, and S. Meri Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation J. Immunol. 181 2008 8433 8440
13. L. Deban, R.C. Russo, M. Sironi, F. Moalli, M. Scanziani, V. Zambelli, I. Cuccovillo, A. Bastone, M. Gobbi, and S. Valentino Regulation of leukocyte recruitment by the long pentraxin PTX3 Nat. Immunol. 11 2010 328 334
14. C. Garlanda, E. Hirsch, S. Bozza, A. Salustri, M. De Acetis, R. Nota, A. Maccagno, F. Riva, B. Bottazzi, and G. Peri Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response Nature 420 2002 182 186
15. C. Garlanda, B. Bottazzi, A. Bastone, and A. Mantovani Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility Annu. Rev. Immunol. 23 2005 337 366
16. J. Golay, M. Lazzari, V. Facchinetti, S. Bernasconi, G. Borleri, T. Barbui, A. Rambaldi, and M. Introna CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 Blood 98 2001 3383 3389
17. E. Gout, C. Moriscot, A. Doni, C. Dumestre-Pérard, M. Lacroix, J. Pérard, G. Schoehn, A. Mantovani, G.J. Arlaud, and N.M. Thielens M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules J. Immunol. 186 2011 5815 5822
18. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
19. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
20. A. Inforzato, A. Doni, I. Barajon, R. Leone, C. Garlanda, B. Bottazzi, and A. Mantovani PTX3 as a paradigm for the interaction of pentraxins with the complement system Semin. Immunol. 25 2013 79 85
21. S. Jaillon, F. Moalli, B. Ragnarsdottir, E. Bonavita, M. Puthia, F. Riva, E. Barbati, M. Nebuloni, L. Cvetko Krajinovic, and A. Markotic The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection Immunity 40 2014 621 632
22. P. Jeannin, B. Bottazzi, M. Sironi, A. Doni, M. Rusnati, M. Presta, V. Maina, G. Magistrelli, J.F. Haeuw, and G. Hoeffel Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors Immunity 22 2005 551 560
23. D. Laoui, E. Van Overmeire, G. Di Conza, C. Aldeni, J. Keirsse, Y. Morias, K. Movahedi, I. Houbracken, E. Schouppe, and Y. Elkrim Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population Cancer Res. 74 2014 24 30
24. M. Lech, C. Römmele, R. Gröbmayr, H. Eka Susanti, O.P. Kulkarni, S. Wang, H.J. Gröne, B. Uhl, C. Reichel, and F. Krombach Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury Kidney Int. 83 2013 647 661
25. R.D. Loberg, C. Ying, M. Craig, L.L. Day, E. Sargent, C. Neeley, K. Wojno, L.A. Snyder, L. Yan, and K.J. Pienta Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo Cancer Res. 67 2007 9417 9424
26. J. Lu, L.L. Marnell, K.D. Marjon, C. Mold, T.W. Du Clos, and P.D. Sun Structural recognition and functional activation of FcgammaR by innate pentraxins Nature 456 2008 989 992
27. Y.J. Ma, A. Doni, T. Hummelshøj, C. Honoré, A. Bastone, A. Mantovani, N.M. Thielens, and P. Garred Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition J. Biol. Chem. 284 2009 28263 28275
28. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
29. M.M. Markiewski, R.A. DeAngelis, F. Benencia, S.K. Ricklin-Lichtsteiner, A. Koutoulaki, C. Gerard, G. Coukos, and J.D. Lambris Modulation of the antitumor immune response by complement Nat. Immunol. 9 2008 1225 1235
30. F. Moalli, A. Doni, L. Deban, T. Zelante, S. Zagarella, B. Bottazzi, L. Romani, A. Mantovani, and C. Garlanda Role of complement and Fcgamma receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus Blood 116 2010 5170 5180
31. P.J. Murray, J.E. Allen, S.K. Biswas, E.A. Fisher, D.W. Gilroy, S. Goerdt, S. Gordon, J.A. Hamilton, L.B. Ivashkiv, and T. Lawrence Macrophage activation and polarization: nomenclature and experimental guidelines Immunity 41 2014 14 20
32. A.J. Nauta, B. Bottazzi, A. Mantovani, G. Salvatori, U. Kishore, W.J. Schwaeble, A.R. Gingras, S. Tzima, F. Vivanco, and J. Egido Biochemical and functional characterization of the interaction between pentraxin 3 and C1q Eur. J. Immunol. 33 2003 465 473
33. G.D. Norata, P. Marchesi, V.K. Pulakazhi Venu, F. Pasqualini, A. Anselmo, F. Moalli, I. Pizzitola, C. Garlanda, A. Mantovani, and A.L. Catapano Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis Circulation 120 2009 699 708
34. R. Olesen, C. Wejse, D.R. Velez, C. Bisseye, M. Sodemann, P. Aaby, P. Rabna, A. Worwui, H. Chapman, and M. Diatta DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans Genes Immun. 8 2007 456 467
35. M.C. Pickering, H.T. Cook, J. Warren, A.E. Bygrave, J. Moss, M.J. Walport, and M. Botto Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nat. Genet. 31 2002 424 428
36. K.J. Pienta, J.P. Machiels, D. Schrijvers, B. Alekseev, M. Shkolnik, S.J. Crabb, S. Li, S. Seetharam, T.A. Puchalski, and C. Takimoto Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer Invest. New Drugs 31 2013 760 768
37. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
38. D. Ricklin, G. Hajishengallis, K. Yang, and J.D. Lambris Complement: a key system for immune surveillance and homeostasis Nat. Immunol. 11 2010 785 797
39. H. Roca, Z.S. Varsos, S. Sud, M.J. Craig, C. Ying, and K.J. Pienta CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization J. Biol. Chem. 284 2009 34342 34354
40. B. Ruffell, N.I. Affara, and L.M. Coussens Differential macrophage programming in the tumor microenvironment Trends Immunol. 33 2012 119 126
41. M. Salio, S. Chimenti, N. De Angelis, F. Molla, V. Maina, M. Nebuloni, F. Pasqualini, R. Latini, C. Garlanda, and A. Mantovani Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction Circulation 117 2008 1055 1064
42. T. Schioppa, R. Moore, R.G. Thompson, E.C. Rosser, H. Kulbe, S. Nedospasov, C. Mauri, L.M. Coussens, and F.R. Balkwill B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis Proc. Natl. Acad. Sci. USA 108 2011 10662 10667
43. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J. Clin. Invest. 122 2012 787 795
44. E. Sierra-Filardi, C. Nieto, A. Domínguez-Soto, R. Barroso, P. Sánchez-Mateos, A. Puig-Kroger, M. López-Bravo, J. Joven, C. Ardavín, and J.L. Rodríguez-Fernández CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile J. Immunol. 192 2014 3858 3867
45. A.C. Soares, D.G. Souza, V. Pinho, A.T. Vieira, J.R. Nicoli, F.Q. Cunha, A. Mantovani, L.F. Reis, A.A. Dias, and M.M. Teixeira Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice Microbes Infect. 8 2006 1321 1329
46. S. Sozzani, F. Sallusto, W. Luini, D. Zhou, L. Piemonti, P. Allavena, J. Van Damme, S. Valitutti, A. Lanzavecchia, and A. Mantovani Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines J. Immunol. 155 1995 3292 3295
47. B. Vogelstein, N. Papadopoulos, V.E. Velculescu, S. Zhou, L.A. Diaz Jr., and K.W. Kinzler Cancer genome landscapes Science 339 2013 1546 1558
48. J.X. Wang, Y.L. He, S.T. Zhu, S. Yang, and S.T. Zhang Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma World J. Gastroenterol. 17 2011 4225 4230
49. H. Watanabe, K. Shimokado, T. Asahara, K. Dohi, and O. Niwa Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas Jpn. J. Cancer Res. 90 1999 40 47
50. D.F. Calvisi, F. Pinna, S. Ladu, R. Pellegrino, M.R. Muroni, M.M. Simile, M. Frau, M.L. Tomasi, M.R. De Miglio, and M.A. Seddaiu Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease Carcinogenesis 29 2008 1639 1647
51. J. Clark, E.L. Clore, K. Zheng, A. Adame, E. Masliah, and D.K. Simon Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice PLoS ONE 5 2010 e12333
52. G. Du, G.A. Drexler, W. Friedland, C. Greubel, V. Hable, R. Krücken, A. Kugler, L. Tonelli, A.A. Friedl, and G. Dollinger Spatial dynamics of DNA damage response protein foci along the ion trajectory of high-LET particles Radiat. Res. 176 2011 706 715
53. B. Muller, G. Peri, A. Doni, V. Torri, R. Landmann, B. Bottazzi, and A. Mantovani Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients Crit. Care Med. 29 2001 1404 1407
54. A.H. Peters, S. Kubicek, K. Mechtler, R.J. O'Sullivan, A.A. Derijck, L. Perez-Burgos, A. Kohlmaier, S. Opravil, M. Tachibana, and Y. Shinkai Partitioning and plasticity of repressive histone methylation states in mammalian chromatin Mol. Cell 12 2003 1577 1589
55. V. Rivieccio, A. Esposito, P. Bellofiore, P. Palladino, M. Sassano, M. Colombo, and A. Verdoliva High-level expression and efficient purification of recombinant human long pentraxin PTX3 in Chinese hamster ovary cells Protein Expr. Purif. 51 2007 49 58
56. J. Shu, H. Fu, G. Qiu, P. Kaye, and M. Ilyas Segmenting overlapping cell nuclei in digital histopathology images Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013 2013 5445 5448